TrialAnnals of the rheumatic diseases2018

Modification of structural lesions on MRI of the sacroiliac joints by etanercept in the EMBARK trial: a 12-week randomised placebo-controlled trial in patients with non-radiographic axial spondyloarthritis.

Walter P Maksymowych et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.